SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending due to excitement over its strategic collaboration with Meta and others to provide nuclear power for data centers, alongside a new U.S. Department of Energy agreement for a radioisotope pilot facility. The community is actively discussing the stock's potential as a key player in powering AI and achieving U.S. energy independence, with many anticipating further developments from an upcoming congressional hearing on nuclear energy and fuel allocation amidst ongoing debate between bullish investors and those concerned about insider selling and pre-revenue status.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas (BOIL) is seeing intense discussion as natural gas prices decline significantly, driven by unusually warm winter forecasts reducing demand and ample supply. The community expresses widespread frustration and concern over persistent losses, debating if the market is oversold or if further drops are imminent. Many are pointing to the inherent decay of the leveraged ETF, while others anticipate a potential polar vortex event to spark a reversal.

Sailana Inu, the sister of legendary Saitama Inu, is bringing back the Wolfpack and OG community vibes that previously sent Saitama to a $7 billion marketcap in 2021. The power of community mixed with great leadership is what will take this project to great heights. Join the movement, join the pack, become apart of the Sailana Army . Together, we will create something that will go down in history, and something that will be talked about years from now.

Sailana Inu

Sailana Crypto is actively trending as its 'Wolfpack' community celebrates the successful launch of WolfSWAP, a cross-chain aggregator offering unique fee-sharing capabilities for other projects. This dedicated focus on building innovative utility beyond traditional memecoins, with further flagship products anticipated, is generating strong bullish sentiment and a vision for decentralizing the sector.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor (OPEN) is trending with significant bullish momentum following news of efforts to reduce mortgage rates, sparking widespread community discussion about a potential short squeeze. The market believes this development could greatly benefit the platform by increasing housing market activity and transaction volumes. While many anticipate a strong upward move, some community members remain cautious about sector-wide hype.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after receiving pivotal FDA feedback, which clarified a de-risked path for its lead therapy, sonelokimab, towards regulatory submission without requiring additional clinical trials. This significant regulatory clarity has ignited widespread community discussion about potential buyouts, particularly by Merck, and the stock's substantial undervaluation. Investors are actively anticipating a major re-rating and a potential short squeeze, with upcoming investor events adding to the positive sentiment.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors digest the potential impact of Fosun Pharma's Wan Ti Le being included on China's National Reimbursement Drug List and analysts anticipate target price raises due to strong IBSRELA sales. The community is weighing potential revenue from China and speculating on milestone payments, while also discussing concerns about patent infringement and generic competition. Some investors express frustration with the stock's price movement despite positive developments, awaiting a CMS resolution.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the market eagerly awaits the anticipated resubmission of its Duchenne muscular dystrophy therapy's Biologics License Application to the FDA, following strong Phase 3 clinical trial data. The community is actively debating the submission timeline and potential regulatory outcomes, with many confident in the therapy's efficacy and commercial prospects while others raise concerns about data presentation and past regulatory challenges. This intense discussion highlights the significant potential for addressing a high unmet need in rare disease and the company's broader exosome platform.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

The nuclear power sector, particularly Small Modular Reactors (SMRs) like NuScale Power, is trending amidst increasing energy demands from AI data centers and anticipated government efforts to streamline nuclear permits. The community is actively discussing the potential for upcoming major contract announcements, recent insider buying, and NuScale's unique advantage as the only company with an NRC-approved SMR design.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

MELANIA CRYPTO is trending amidst intense community debate, primarily driven by ongoing discussions about alleged insider token distribution and speculative rumors of upcoming catalysts like a related movie or new exchange listings. Many in the community are actively questioning its legitimacy, citing significant past losses and a 'pump and dump' narrative. The discourse often links it to other politically-themed digital assets, underscoring persistent concerns about market manipulation and perceived 'grifting' within this speculative sector.

United States Commodity Funds LLC - United States Natural Gas Fund

United States Natural Gas Fund, LP

United States Natural Gas Fund (UNG) is experiencing extreme volatility driven by rapidly shifting winter weather forecasts, leading to sharp disagreements among traders. The community is actively debating whether to 'buy the dip' on hopes of sustained cold or 'short bounces' amid fluctuating demand and ample supply. Underlying the short-term swings, conversations are also influenced by strong LNG export figures and the potential for AI data centers to create new structural demand for natural gas.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kingstone Companies (NASDAQ:KINS) Share Price Passes Above 50 Day Moving Average - What's Next?

Kingstone Companies (NASDAQ:KINS) Shares Pass Above 50 Day Moving Average - Time to Sell...

Squarepoint Ops LLC Grows Stake in Kingstone Companies, Inc $KINS

Squarepoint Ops LLC boosted its stake in shares of Kingstone Companies, Inc (NASDAQ:KINS - Free Report) by 201.9% during the 2nd quarter, according to its most recent disclosure with the Securities...

Panagora Asset Management Inc. Makes New Investment in Kingstone Companies, Inc $KINS

Panagora Asset Management Inc. purchased a new position in Kingstone Companies, Inc (NASDAQ:KINS - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities...

Kingstone Companies (NASDAQ:KINS) Share Price Crosses Below Two Hundred Day Moving Average - Here's Why

Kingstone Companies (NASDAQ:KINS) Stock Price Crosses Below Two Hundred Day Moving Average - Here's Why...

Angel Oak Capital Advisors LLC Sells 84,990 Shares of Kingstone Companies, Inc $KINS

Angel Oak Capital Advisors LLC lowered its holdings in Kingstone Companies, Inc (NASDAQ:KINS - Free Report) by 38.2% in the 2nd quarter, according to the company in its most recent filing with the...

Kingstone Companies (NASDAQ:KINS) Releases Earnings Results, Beats Expectations By $0.12 EPS

Kingstone Companies (NASDAQ:KINS - Get Free Report) issued its quarterly earnings data on Thursday. The insurance provider reported $0.73 earnings per share (EPS) for the quarter, topping analysts...

Kingstone Companies (NASDAQ:KINS) Stock Rating Lowered by Wall Street Zen

Wall Street Zen cut Kingstone Companies from a "strong-buy" rating to a "buy" rating in a report on Saturday...

Kindred Biosciences is a veterinary biotechnology company, focuses on developing therapies for dogs, cats, and horses. It develops canine, feline, and equine antibodies for the treatment of diseases in companion animals. Its strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for animal companions. Their mission is to bring innovative biologics to veterinary medicine because they believe their pets deserve the same kinds of safe and effective medicines that human family members enjoy. The company was incorporated in 2012 and is based in San Francisco, California.

Kindred Biosciences Inc

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

KIN
Kindred Biosciences Inc

Feed

News

Sentiment

Fundamentals

Info

Latest KIN News

KINKindred Biosciences Inc